Evidence map›Paper›PMID 42563563›Full record

ArticleInternational journal of cancer2026

Risk Factors for Estrogen Receptor Subtype-Specific Contralateral Breast Cancer in Women Under Age 55 Years.

Anne S Reiner, Kathleen E Malone, Charles F Lynch, Lene Mellemkjær, Julia A Knight, Esther M John, Xiaolin Liang, Meghan Woods, WECARE Study Collaborative Group, Jonine L Bernstein

Abstract read
In one paragraph

Article in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anne S ReinerMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-1258-6112
Kathleen E MaloneFred Hutchinson Cancer Center, Seattle, Washington, USA.
Charles F LynchUniversity of Iowa, Iowa City, Iowa, USA.
Lene MellemkjærDanish Cancer Institute, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-9222-6215
Julia A KnightUniversity of Toronto, Dalla Lana School of Public Health, Toronto, Canada.ORCID https://orcid.org/0000-0002-7610-7635
Esther M JohnStanford School of Medicine, Stanford, California, USA.ORCID https://orcid.org/0000-0003-3259-8003
Xiaolin LiangMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Meghan WoodsMemorial Sloan Kettering Cancer Center, New York, New York, USA.
WECARE Study Collaborative Group
Jonine L BernsteinMemorial Sloan Kettering Cancer Center, New York, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI FRANCESCA M GANY · 1985 to 2026
$347.4M
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast CancerR01CA129639 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BERNSTEIN, JONINE L. · 2009 to 2013
$15.6M
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENEU01CA083178 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BERNSTEIN, JONINE LISA · 1999 to 2003
$9.3M
Molecular pathoepidemiology of contralateral breast cancerR01CA206464 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BERNSTEIN, JONINE L., MALONE, KATHLEEN E · 2017 to 2022
$7.0M
Interaction of Radiation, BRCA1/2, and Breast CancerR01CA097397 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BERNSTEIN, JONINE LISA · 2002 to 2006
$4.1M
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized riskR21CA234752 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BERNSTEIN, JONINE L., OH, JUNG HUN · 2020 to 2021
$462k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA097397NCI NIH HHS R01 CA129639NCI NIH HHS R01 CA206464NCI NIH HHS R21 CA234752NCI NIH HHS U01 CA083178NIH HHS CA083178NIH HHS CA097397NIH HHS CA129639NIH HHS CA206464NIH HHS CA234752NIH HHS P30CA008748
6 · The paper itself

Abstract

Women with estrogen receptor negative (ER-) contralateral breast cancer (CBC) are 50% more likely to die of CBC compared to women with estrogen receptor positive (ER+) CBC. We comprehensively investigated risk factors for ER subtype-specific CBC using the Women's Environmental Cancer and Radiation Epidemiology Study, a population-based, case-control study of 1521 CBC cases under age 55 years and 2212 individually matched unilateral breast cancer controls. Information about breast cancer risk factors and ER status was obtained by interview and medical record abstraction and common genetic variants with GWAS. Multivariable rate ratios and 95% confidence intervals were estimated using conditional logistic regression models, adjusting for known and suspected risk factors. Among 2800 women where the matched case had known ER CBC status, chemotherapy, hormone therapy, and increasing number of full-term pregnancies were associated with decreased ER+ CBC risk. Drinking, smoking, first breast cancer lobular histology, first-degree breast cancer family history, a polygenic risk score (PRS) of 313 common variants, and an ER+ subtype-specific PRS were associated with increased ER+ CBC risk. More than 2 years of breastfeeding was associated with decreased ER- CBC risk. While none of the PRSs were associated with ER- CBC risk, first- and second-degree family history of breast cancer and second-degree family history of ovarian cancer were associated with increased ER- CBC risk. We identified differential risk factors for ER subtype-specific CBC which can inform individualized risk prediction models for future clinical impact. There remains an unexplained genetic component of ER- CBC.

Indexed as

contralateral breast cancerERestrogen receptorpopulation‐based

Identifiers

PMID42563563
PMCPMC13454970

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.